BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/6/2016 5:24:00 PM | Browse: 1345 | Download: 2981
 |
Received |
|
2016-09-12 10:58 |
|
Peer-Review Started |
|
2016-09-12 15:48 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-10-12 10:18 |
|
Revised |
|
2016-10-18 00:15 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-11-08 17:29 |
|
Second Decision by Editor-in-Chief |
|
2016-11-08 23:16 |
|
Final Decision by Editorial Office Director |
|
2016-11-16 11:43 |
|
Articles in Press |
|
2016-11-16 11:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-11-24 18:49 |
|
Publish the Manuscript Online |
|
2016-12-06 17:24 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic value of glycated hemoglobin in colorectal cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Patrizia Ferroni, Vincenzo Formica, David Della-Morte, Jessica Lucchetti, Antonella Spila, Roberta D'Alessandro, Silvia Riondino, Fiorella Guadagni and Mario Roselli |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| European Social Fund, under the Italian Ministry of Education, University and Research |
PON03PE_00146_1/10 BIBIOFAR (CUP B88F12000730005) |
|
| Corresponding Author |
Patrizia Ferroni, MD, PhD, San Raffaele Roma Open University, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy. patrizia.ferroni@sanraffaele.it |
| Key Words |
Colorectal cancer; Type 2 diabetes; Glycated hemoglobin; Insulin resistance; Prognostic value |
| Core Tip |
The clinical significance of routinely used pre-treatment fasting blood glucose, insulin, HbA1c and homeostasis model of risk assessment was investigated in a cohort of colorectal cancer (CRC) patients. Despite all four metabolic markers were elevated in non-diabetic CRC patients, only elevated HbA1c levels were significantly associated with advanced CRC stage and disease progression, showing a negative prognostic value both in terms of progression-free (HR = 1.24) and overall (HR = 1.36) survival after adjustment for major confounders. These results suggest that glycemic metabolic markers, mainly HbA1c, should be carefully monitored in CRC patients as they could provide important risk stratification information.
|
| Publish Date |
2016-12-06 17:24 |
| Citation |
Ferroni P, Formica V, Della-Morte D, Lucchetti J, Spila A, D’Alessandro R, Riondino S, Guadagni F, Roselli M. Prognostic value of glycated hemoglobin in colorectal cancer. World J Gastroenterol 2016; 22(45): 9984-9993
|
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i45/9984.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i45.9984 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
